Questions About Cancer? 1-800-4-CANCER
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Gynecologic Steering Committee

The NCI Gynecologic Cancer Steering Committee (GCSC) was transitioned into a NCI Disease Specific Steering Committee from the Gynecologic Cancer Intergroup in May 2006. The GCSC is currently composed of the Steering Committee and three specific disease-site task forces. Members of the GCSC include Cooperative Group gynecologic disease committee chairs, Specialized Programs of Research Excellence (SPOREs), Cancer Center, and R01/P01 investigators along with community oncologists, biostatistician(s), patient advocates, and NCI staff.

Mission Statement

The GCSC functions to harmonize an efficient, cost-effective, science-driven, and transparent process that will identify and promote the "Best Science" in gynecologic cancer clinical research by addressing the design and prioritization of phase III trials and evaluating randomized phase II studies. As part of its mission, this GCSC is intent on fostering collaboration with international groups and institutions engaged in conducting trials in gynecologic cancers.

Roster of Gynecologic Cancer Steering Committee (GCSC) members
Michael J. Birrer, M.D., Ph.D., David M. Gershenson, M.D., and David Gaffney, M.D., Ph.D., Co-chairs

Task Forces

  • Cervical Cancer: Alan Covens, M.D., and Don S. Dizon, M.D., Co-chairs
  • Ovarian Cancer: Carol Aghajanian, M.D., and Kunle Odunsi, M.D., Co-chairs
  • Uterine Cancer: Martee Hensley, M.D., and Scott McMeekin, M.D., Co-chairs

Clinical Trials Planning Meetings (CTPMs)

The Goal of CTPMs is to:

  • identify strategic directions for clinical trials in a specific field
    • reach consensus on the most important clinical trials to conduct;
    • identify portfolio gaps and emerging scientific opportunities;
    • identify innovative trial design opportunities;
  • facilitate innovation and collaboration among the broad oncology community active in the specific cancer under study

List of Clinical Trial Planning Meetings (CTPM) Executive Summaries and Publications


To search all active clinical trials, go to:


  • Kitchner, H. C. and Trimble, E.L. Endometrial Cancer State of the Science Meeting . Int J Gynecol Cancer, 2009;19:134-140.
  • Trimble, E. L. (for the Cervical SOTS writing Committee). Cervical Cancer State-of-the-Clinical-Science Meeting on Pretreatment Evaluation and Prognostic Factors, September 27-28, 2007: Proceedings and Recommendations. Gynecol Oncol, accepted for publication.

CCCT Contact: Jean M. Lynn, RN, MPH, OCN